The Indianapolis-based company received U.S. regulatory approval last week for its second medicine in 18 months in what it ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Department of Agriculture (USDA) has granted the company a license for CYTOPOINT™, the first monoclonal antibody ...

Every day, itchy dogs shuffle into Elizabeth Falk’s veterinary office. Some can’t stop chewing their feet or scratching their bellies. Others have red, smelly ears, or rashes on their skin. All are ...

Cytopoint targets and neutralizes canine interleukin-31 (cIL-31), a key protein involved in triggering itch in dogs. Administered by injection once monthly, Cytopoint provides fast, long-lasting ...

Seasonal allergies affect approximately 10-15% of the dog and cat population, causing discomfort and distress to our beloved pets. 2 Spot Pet Insurance's data team examined claims involving Cytopoint ...